ReNAP Group aims to develop technical and indigenous knowledge by relying on domestic potential to produce biotechnological products, mainly pharmaceuticals based on mRNA technology. The company's first project was the production of GFP mRNA and then VEGF mRNA. Following the global outbreak of coronavirus with the knowledge and technical infrastructure for the production of preventive vaccines, especially the corona vaccine under the brand name Corenapcin was put on the agenda with the support of the Vice President for Science and Technology. Sanctions and other necessary infrastructure were established and provided by ReNAP scientists.